US Cardiometabolic Disease Market: Innovative Disease Management Strategies 2034
The US Cardiometabolic Disease Market is supported by a substantial burden of obesity, diabetes, hypertension, and cardiovascular disorders. Extensive healthcare infrastructure and widespread access to specialist care are supporting integrated approaches to cardiometabolic disease management. The cardiometabolic disease market is expected to reach US$ 155.56 billion by 2034 from US$ 109.28...
0 Reacties 0 aandelen 334 Views 0 voorbeeld